Vritmeta 35 MR Tablet
Prescription Required
Product introduction
Vritmeta 35 MR Tablet is an anti-anginal medicine used for treating heart-related chest pain (angina). It prevents new attacks of angina but does not stop an acute attack once it has started. It can be used alone or in combination with some other medicines.
Vritmeta 35 MR Tablet is a medicine used for treating heart-related chest pain (angina) caused due to narrowing of blood vessels of the heart. It effectively prevents new attacks of angina but does not stop an acute attack once it has started. This medicine should be used along with lifestyle changes like healthy diet, regular exercise, and smoking cessation for best results. It is used as an add-on therapy for patients who are not relieved by or are intolerant to the initial medicines. It should not be stopped abruptly. Headache, vomiting, and dizziness may be seen as side effects.
Vritmeta 35 MR Tablet is a medicine used for treating heart-related chest pain (angina) caused due to narrowing of blood vessels of the heart. It effectively prevents new attacks of angina but does not stop an acute attack once it has started. This medicine should be used along with lifestyle changes like healthy diet, regular exercise, and smoking cessation for best results. It is used as an add-on therapy for patients who are not relieved by or are intolerant to the initial medicines. It should not be stopped abruptly. Headache, vomiting, and dizziness may be seen as side effects.
Uses of Vritmeta Tablet MR
Benefits of Vritmeta Tablet MR
In Treatment of Angina (heart-related chest pain)
Angina is chest pain or discomfort that happens when there is not enough oxygen-rich blood going to part of your heart. This can occur when the blood vessels of the heart become narrow. By preserving energy metabolism in cells exposed to reduced oxygen supply, Vritmeta 35 MR Tablet prevents a decrease in intracellular energy levels, thereby ensuring the proper functioning of heart muscle cells. Vritmeta 35 MR Tablet can also help increase your ability to exercise and lead your daily life more easily by reducing the frequency of angina attacks. You should take it regularly and as long as it is prescribed for it to work effectively.
Research shows that the frequency of angina attacks reduces significantly after 6 months of treatment with Vritmeta 35 MR Tablet.
Research shows that the frequency of angina attacks reduces significantly after 6 months of treatment with Vritmeta 35 MR Tablet.
Side effects of Vritmeta Tablet MR
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Vritmeta
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Rash
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
How to use Vritmeta Tablet MR
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vritmeta 35 MR Tablet is to be taken with food.
How Vritmeta Tablet MR works
Vritmeta 35 MR Tablet is an anti-anginal medication. It decreases the oxygen requirement of the heart by shifting its metabolism from fats to glucose. As a result, the heart works more efficiently.
Safety advice
Alcohol
UNSAFE
Vritmeta 35 MR Tablet may cause excessive drowsiness with alcohol.
Pregnancy
CONSULT YOUR DOCTOR
Information regarding the use of Vritmeta 35 MR Tablet during pregnancy is not available. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Vritmeta 35 MR Tablet during breastfeeding is not available. Please consult your doctor.
Driving
UNSAFE
Vritmeta 35 MR Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Vritmeta 35 MR Tablet should be used with caution in patients with kidney disease. Dose adjustment of Vritmeta 35 MR Tablet may be needed. Please consult your doctor.
Use of Vritmeta 35 MR Tablet is not recommended in patients with severe kidney disease.
Use of Vritmeta 35 MR Tablet is not recommended in patients with severe kidney disease.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Vritmeta 35 MR Tablet in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Vritmeta 35 MR Tablet
₹15.9/Tablet MR
Flavedon MR Tablet
Serdia Pharmaceuticals India Pvt Ltd
₹13.09/tablet mr
13% cheaper
Carvidon -MR Tablet
Micro Labs Ltd
₹15.5/tablet mr
3% costlier
Trivedon MR Tablet
Cipla Ltd
₹17.1/tablet mr
13% costlier
FLAVMOX 35MG TABLET MR
Maxlive Pharmaceuticals Pvt Ltd
₹9.2/tablet mr
39% cheaper
Trimezen 35mg Tablet MR
Elder Pharmaceuticals Ltd
₹8/tablet mr
47% cheaper
Quick tips
- Vritmeta 35 MR Tablet prevents new attacks of angina but does not stop an acute attack.
- Does not affect heart rate, blood pressure at rest or during exercise.
- Improves HbA1c and blood sugar levels in diabetes patients.
- Avoid driving or using machinery if you feel dizzy after taking Vritmeta 35 MR Tablet.
Fact Box
Chemical Class
Phenylmethylamines
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Fatty acid modulator & Sodium channel blocker
Patient concerns
FAQs
Is Vritmeta 35 MR Tablet a beta blocker?
No, Vritmeta 35 MR Tablet is not a beta blocker. It is an anti-anginal medicine which is used in combination with other medicines to treat angina pectoris (chest pain caused by coronary disease). It protects the heart cells from getting affected by the reduced oxygen supply during an episode of angina.
Who should not take Vritmeta 35 MR Tablet?
You should not take Vritmeta 35 MR Tablet if you are allergic to it or have severe kidney problems. Patients with Parkinson’s disease should also avoid taking Vritmeta 35 MR Tablet. Parkinson’s disease is a disease of the brain which affects movement and causes trembling, rigid posture, slow movements and a shuffling, unbalanced walk.
Can Vritmeta 35 MR Tablet be used in elderly patients?
Vritmeta 35 MR Tablet should be used with caution in patients aged more than 75 years of age. Usually, a lower dose is prescribed in elderly patients to reduce the chances of adverse effects. It is important to continuously monitor such patients.
Does taking Vritmeta 35 MR Tablet increases the risk of falling down frequently?
Though it is rare, falls may occur with use of Vritmeta 35 MR Tablet. This may be due to instability while walking or fall in blood pressure while standing up. The risk may be higher in elderly patients. Therefore, they need to be more careful and should be monitored.
Does Vritmeta 35 MR Tablet cause drowsiness?
Yes, Vritmeta 35 MR Tablet may make you feel dizzy and drowsy. Therefore, you should avoid driving or using heavy machinery in case it causes these side effects.
How should Vritmeta 35 MR Tablet be taken?
You should take Vritmeta 35 MR Tablet exactly as prescribed by your doctor. It is meant for oral use. So, take the tablets with sufficient amount of liquid, e.g. a glass of water. You can take this medicine with or without food.
What are the possible side effects of Vritmeta 35 MR Tablet?
The common side effects of Vritmeta 35 MR Tablet include dizziness, headache, abdominal pain, diarrhea, indigestion, and hives, rash and itching. Its use may also make you feel sick and weak. The rare side effects may include fast or irregular heartbeats (also called palpitations), fall in blood pressure on standing which can further cause dizziness, lightheadedness or fainting, fall, and flushing.
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Trimetazidine dihydrochloride. Suresnes Cedex, France: Les Laboratoires Servier; 2001 [revised 27 Mar. 2007]. [Accessed 20 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from:
- CiplaMed. Trimetazidine dihydrochloride [Prescribing Information]. [Accessed 07 Aug. 2023]. (online) Available from:
- Trimetazidine dihydrochloride [Package leaflet: Information for the user]. Gidy, France: Les Laboratoires Servier Industrie; 2021. [Accessed 07 Aug. 2023]. (online) Available from:
- Ciapponi A, Pizarro R, Harrison J. WITHDRAWN: Trimetazidine for stable angina. Cochrane Database Syst Rev. 2017 Mar 20;3(3):CD003614. [Accessed 07 Aug. 2023]. (online) Available from:
Marketer details
Name: Vridam Healthcare Pvt Ltd
Address: Plot No-3, Sr. No. 323, 2B, Dnyaneshwar Nagar, Pathardi Phata, Nashik, Maharashtra 422009, Mobile No. 9970325741
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹159
Inclusive of all taxes
10.0 tablet mr in 1 strip
SOLD OUT
Notify me